MANTLE CELL LYMPHOMA (MCL) HAS A POORER PROGNOSIS THAN FOLLICULAR NON-HODGKINS-LYMPHOMA (F-NHL) - HOWEVER, HIGH-DOSE THERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) MAY OVERCOME TREATMENT RESISTANCE IN MCL

Authors
VOSE JM WEISENBURGER DD ANDERSON JR BIERMAN PJ BAST M CHAN WJ BISHOP MR ARMITAGE JO
Citation
Jm. Vose et al., MANTLE CELL LYMPHOMA (MCL) HAS A POORER PROGNOSIS THAN FOLLICULAR NON-HODGKINS-LYMPHOMA (F-NHL) - HOWEVER, HIGH-DOSE THERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) MAY OVERCOME TREATMENT RESISTANCE IN MCL, Blood, 82(10), 1993, pp. 10000135-10000135
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
82
Issue
10
Year of publication
1993
Supplement
1
Pages
10000135 - 10000135
Database
ISI
SICI code
0006-4971(1993)82:10<10000135:MCL(HA>2.0.ZU;2-A